N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine

C17H31N7O4 — CID 54198381

IUPACN'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine
SMILESCC(N=O)C(C)(C)NCCCNC(C)(C)C(CCn1ccnc1[N+](=O)[O-])N=O
InChIInChI=1S/C17H31N7O4/c1-13(21-25)16(2,3)19-8-6-9-20-17(4,5)14(22-26)7-11-23-12-10-18-15(23)24(27)28/h10,12-14,19-20H,6-9,11H2,1-5H3
InChIKeyPNLUJLDXLCKENZ-UHFFFAOYSA-N
MW397.48 g/mol
LogP2.60
Rot. Bonds14

About N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine

N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine (PubChem CID 54198381) has the molecular formula C17H31N7O4 and a molecular weight of 397.48 g/mol. Its IUPAC name is N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine.

Molecular Properties

Compound NameN'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine
PubChem CID54198381
Molecular FormulaC17H31N7O4
Molecular Weight397.48 g/mol
Exact Mass397.24
IUPAC NameN'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine
SMILESCC(N=O)C(C)(C)NCCCNC(C)(C)C(CCn1ccnc1[N+](=O)[O-])N=O
InChIInChI=1S/C17H31N7O4/c1-13(21-25)16(2,3)19-8-6-9-20-17(4,5)14(22-26)7-11-23-12-10-18-15(23)24(27)28/h10,12-14,19-20H,6-9,11H2,1-5H3
InChIKeyPNLUJLDXLCKENZ-UHFFFAOYSA-N
XLogP2.60
TPSA143.88 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds14
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500397.48
LogP ≤ 52.60
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine?
The IUPAC name of N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine (CID 54198381) is N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine.
What is the SMILES notation for N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine?
The canonical SMILES for N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine is CC(N=O)C(C)(C)NCCCNC(C)(C)C(CCn1ccnc1[N+](=O)[O-])N=O.
What is the InChIKey of N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine?
The InChIKey is PNLUJLDXLCKENZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H31N7O4/c1-13(21-25)16(2,3)19-8-6-9-20-17(4,5)14(22-26)7-11-23-12-10-18-15(23)24(27)28/h10,12-14,19-20H,6-9,11H2,1-5H3.
What are the key properties of N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine?
N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine has a molecular weight of 397.48 g/mol, XLogP of 2.60, 14 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N'-[2-methyl-5-(2-nitroimidazol-1-yl)-3-nitrosopentan-2-yl]-N-(2-methyl-3-nitrosobutan-2-yl)propane-1,3-diamine is sourced from PubChem (CID 54198381), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).